NEUROMEDICAL SYSTEMS' LAUNCHING PAPNET ANALYZER DEC. 1 AT PRICE TO LABS OF $18 PER TEST; PLANNED IPO TO NET $75.1 MIL., FUND MARKETING AND EXPANSION EFFORT
This article was originally published in The Gray Sheet
Executive Summary
Neuromedical Systems, Inc. is rolling out its Papnet adjunctive Pap smear analyzer Dec. 1 following FDA approval of the product's premarket approval application Nov. 8. Neuromedical Systems, Inc. is offering the system, designed to increase detection of positive samples, to labs at a cost of $18 per slide. NSI estimates the cost to patients at $35.